Moncyte is a research-to-business project at the University of Helsinki.
We have a unique solution that sheds light on why some people respond differently to cholesterol-lowering drugs, opening new ways for personalized medicine and improving patient lives.
Simon Pfisterer, PhD
Dr. Simon Pfisterer is an independent research group leader at the Department of Anatomy, University of Helsinki (www.pfistererlab.org). Simon has more than seven years’ experience in laboratory automation and cellular lipid metabolism. Simon has a strong international background and performed research in various countries, including Australia, USA, Germany and Finland.
Tamara Alagirova, MBA
Tamara Alagirova is a business professional with over 15 years of experience in international sales, marketing and business development in medical devices, diagnostics and pharma. Tamara is fluent in seven languages, she has lived in several countries managing cross-functional teams in commercialization and launch of innovations.
Iryna Hlushchenko, PhD
Iryna Hlushchenko has obtained her PhD in Physiology and Neuroscience at University of Helsinki, Finland. Iryna is expert in Python data analysis and primary cell handling. She has been involved in research of hypercholesterolemia and is highly experienced in automated image and data analysis.
Meet us during Nordic Life Science at the Health Capital Helsinki stand and hear our pitch during Rising Stars pitching session!
Moncyte R&D team targets optimal cholesterol-lowering therapy.
Come and meet us at #SLUSH21 at the stand of University of Helsinki on Dec 1-2!
MONCYTE is one of the finalists at YScience Pitching Competition, register and attend the event live on Dec 1.
MONCYTE – personalized and targeted therapies for high cholesterol.